分流器
医学
流量(数学)
生物医学工程
动脉瘤
材料科学
放射科
机械
物理
作者
Juan Vivanco‐Suarez,Aarón Rodríguez-Calienes,Mahmoud Dibas,Milagros Galecio‐Castillo,Cristian Morán‐Mariños,Fernando Terry,Mudassir Farooqui,Santiago Ortega‐Gutiérrez
标识
DOI:10.1136/jnis-2023-snis.243
摘要
Background/Purpose The use of flow diverters (FDs) for the treatment of intracranial aneurysms has continually increased due to their proven safety and effectiveness. However, one of the main concerns after FD implantation is the risk of thromboembolic events, which are prevented by the concomitant prescription of dual antiplatelet therapy (DAPT). Newer devices with anti-thrombogenic surface modifications are currently available. The use of single antiplatelet therapy after the implantation of surface-modified FDs has been reported in studies with a limited sample size and follow-up time. Herein, we sought to evaluate the safety of surface-modified FDs with SAPT for the treatment of intracranial aneurysms using a systematic review and aggregate meta-analysis of all available literature. Methods We performed a systematic search from inception until November 2022 for all the studies evaluating outcomes after treatment with surface-modified FDs for intracranial aneurysms using SAPT. Primary safety outcomes were treatment-related ischemic, hemorrhagic, and overall events. Random-effects meta-analyses were used to calculate proportions, and statistical heterogeneity was assessed. Results A total of 12 studies with 268 patients harboring 327 aneurysms were included. Age ranged between 21-84 years, and 53% were females. Most aneurysms were unruptured (68%), saccular (84%), and located in the anterior circulation (92%). Aneurysm neck ranged between 1.2-17 mm. The most common surface-modified FDs were the p48 and p64 with hydrophilic polymer-coated (66% of the studies), followed by the Pipeline Flex Shield in 25%. More than one FD was implanted in 10% of the patients, and adjunctive coiling was used in 17%. SAPT with prasugrel was the most common regimen (50% of the studies), followed by various regimens of aspirin in 25%. However, the SAPT regimens were variable. The pooled rate of ischemic events was 9% (95% confidence interval [CI] 3%-23%, I2=54%), hemorrhagic events 4% (95% CI 2%-7%, I2=0%), and overall events 13% (95% CI 6%-29%, I2=57%). Conclusions The use of surface-modified FDs in the treatment of ruptured and unruptured aneurysms is feasible with a low rate of hemorrhagic events. However, the rate of ischemic events was non-negligible, which suggests caution should be taken if the decision is to implant a surface-modified FD with SAPT. Further studies evaluating outcomes of the specific SAPT protocols and homogenous surface-modified technology are needed to better define safety profiles. Disclosures J. Vivanco-Suarez: None. A. Rodriguez-Calienes: None. M. Dibas: None. M. Galecio: None. C. Moran-Mariños: None. F. Terry: None. M. Farooqui: None. S. Ortega-Gutierrez: None.
科研通智能强力驱动
Strongly Powered by AbleSci AI